Structural Elucidation of Light Activated Vesicles
Source abstract
Abstract
In the present study, synchrotron small-angle X-ray scattering (SAXS) combined with a UV light source (in situ SAXS-UV irradiation) was used to determine the structure response of gold nanoparticle (NP)-loaded vesicles. The investigated system consisted of multilamellar vesicles of N-methylated dioleoylphosphatidylethanolamine (DOPE-Me) containing hydrophilic gold NPs with a size of 40 Å. Our results indicate drastic optothermically induced structural changes in these gold NP-loaded aqueous dispersions, which are accompanied by strong alterations in the phospholipid membrane permeability. A structural mechanism from well-ordered multilamellar vesicles in the fluid lamellar (L α ) phase to an inverted type hexagonal liquid crystalline (H 2 ) phase via the formation of an intermediate phase of uncorrelated fluid bilayers is proposed. In general, these investigations are also crucial for the understanding of the potential of gold NP-loaded model phospholipid systems as efficient drug nanocarriers aiming to improve drug targeting and releasing on demand.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Lipid Membrane Structure and Behavior · Gold and Silver Nanoparticles Synthesis and Applications · Sphingolipid Metabolism and Signaling
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Faculty of Pharmaceutical Sciences, Department of Pharmaceutics and Analytical Chemistry, University of Copenhagen, Copenhagen, Denmark
Centre for Drug Research, University of Helsinki, Helsinki, Finland
Division of Biopharmacy and Pharmacokinetics, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland
Institute of Biophysics and Nanosystems Research (IBN), Austrian Academy of Sciences, Graz, Austria
References (26)
Show source-provided references
1. Paasonen L. · J. Controlled Release · 2007 · 122 · 8610.1016/j.jconrel.2007.06.009 ↗
2. Yliperttula M. · Eur. J. Pharm. Sci. · 2008 · 35 · 15110.1016/j.ejps.2008.04.012 ↗
3. Li J. · J. Macromol. Sci., Part A: Pure Appl. Chem. · 2008 · 45 · 83310.1080/10601320802300685 ↗
4. Wu G. H. · J. Am. Chem. Soc. · 2008 · 130 · 817510.1021/ja802656d ↗
5. del Amo E. M. · Drug Discovery Today · 2008 · 13 · 13510.1016/j.drudis.2007.11.002 ↗
6. Lu J. · Small · 2008 · 4 · 42110.1002/smll.200700903 ↗
7. Fong W. K. · J. Controlled Release · 2009 · 135 · 21810.1016/j.jconrel.2009.01.009 ↗
8. Robbins G. P. · J. Am. Chem. Soc. · 2009 · 131 · 387210.1021/ja808586q ↗
9. Kojima C. · Colloids Surf. B · 2008 · 66 · 24610.1016/j.colsurfb.2008.06.022 ↗
10. Richardson H. H. · Nano Lett. · 2009 · 9 · 113910.1021/nl8036905 ↗
11. Siegel D. P. · Biophys. J. · 1999 · 76 · 29110.1016/S0006-3495(99)77197-3 ↗
12. Siegel D. P. · Biophys. J. · 1997 · 73 · 308910.1016/S0006-3495(97)78336-X ↗
13. Harroun T. A. · Biochim. Biophys. Acta · 2003 · 1617 · 6210.1016/j.bbamem.2003.09.003 ↗
14. Yaghmur A. · PLoS ONE · 2008 · 3 · e207210.1371/journal.pone.0002072 ↗
15. Gruner S. M. · Biochemistry · 1988 · 27 · 285310.1021/bi00408a029 ↗
16. Patton J. S. · Science · 1979 · 204 · 14510.1126/science.432636 ↗
17. Hui S. W. · Science · 1981 · 212 · 92110.1126/science.7233185 ↗
18. Yaghmur A. · PLoS ONE · 2008 · 3 · e374710.1371/journal.pone.0003747 ↗
19. Siegel D. P. · Biochemistry · 1989 · 28 · 370310.1021/bi00435a012 ↗
20. Siegel D. P. · Biophys. J. · 2006 · 90 · 20010.1529/biophysj.105.070466 ↗
21. Cherezov V. · J. Membr. Biol. · 2003 · 195 · 16510.1007/s00232-003-0617-z ↗
22. Rappolt M. · Biophys. J. · 2003 · 84 · 311110.1016/S0006-3495(03)70036-8 ↗
23. Laggner P. · Chem. Phys. Lipids · 1991 · 57 · 12110.1016/0009-3084(91)90072-J ↗
24. Mares T. · J. Phys. Chem. B · 2008 · 112 · 1657510.1021/jp805715r ↗
25. Amenitsch H. · J. Synchrotron Rad. · 1998 · 5 · 50610.1107/S090904959800137X ↗
26. Huang T. C. · J. Appl. Crystallogr. · 1993 · 26 · 18010.1107/S0021889892009762 ↗